Category of Chemicals

LRRK2 inhibitors are a class of pharmaceutical compounds designed to target and modulate the activity of leucine-rich repeat kinase 2 (LRRK2). Mutations in the LRRK2 gene have been linked to an increased risk of developing Parkinson's disease, making LRRK2 an attractive target for potential treatments. By inhibiting LRRK2 activity, these inhibitors aim to slow down the progression of Parkinson's disease or reduce its associated symptoms. Research into LRRK2 inhibitors is ongoing, and their development holds promise for novel therapies to combat this neurodegenerative disorder.